Income Statement Khimprom Moscow Micex - RTS

Stocks

HIMC

RU0009098990

Commodity Chemicals

Delayed Moscow Micex - RTS Other stock markets 2020-08-10			5-day change	1st Jan Change
0.9900 ^RUB	-.--%		-.--%	-

25-02-28	Khimprom Public Joint stock company Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-07-29	Khimprom Public Joint stock company Reports Earnings Results for the Half Year Ended June 30, 2024	CI

b44b58e5520e4d13742ba4bba0c4c.XEMNzhYchqFh4RF_E7SiuwZLsd0rncrJpXc-rL3HZcI.EnJ-q2dDxew2jyIyJOTYiW0S_ekc6YCi4hp62dH3N6FoGmGLU37D1DiDdg

Published financial data: KHIMPROM

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	14.55B	14.98B	16.37B	17.49B	16.29B
Total Revenues	14.55B	14.98B	16.37B	17.49B	16.29B
Cost of Goods Sold, Total	10.1B	11.19B	9.03B	10.28B	10.47B
Gross Profit	4.45B	3.79B	7.34B	7.21B	5.81B
Selling General & Admin Expenses, Total	2.18B	2.21B	2.33B	3.15B	4.07B
Provision for Bad Debts	-	-	-	-	-
Other Operating Expenses	724M	405M	505M	130M	-14.92M
Other Operating Expenses, Total	2.9B	2.61B	2.83B	3.28B	4.06B
Operating Income	1.55B	1.18B	4.51B	3.93B	1.76B
Interest Expense, Total	-388M	-429M	-599M	-334M	-644M
Interest And Investment Income	18.99M	35.89M	106M	182M	389M
Net Interest Expenses	-369M	-394M	-493M	-153M	-255M
Currency Exchange Gains (Loss)	-72.88M	-3.2M	-100M	-31.03M	-35.38M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	1.1B	783M	3.92B	3.74B	1.46B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	82.21M	223M	21.86M	91.5M	155M
Asset Writedown	-	-	-210M	-128M	-
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	1.19B	1.01B	3.73B	3.71B	1.62B
Income Tax Expense	290M	244M	724M	807M	432M
Earnings From Continuing Operations	897M	762M	3.01B	2.9B	1.19B
Net Income to Company	897M	762M	3.01B	2.9B	1.19B
Minority Interest	-	-	-	-	-
Net Income - (IS)	897M	762M	3.01B	2.9B	1.19B
Preferred Dividend and Other Adjustments	83.16M	82.65M	304M	238M	103M
Net Income to Common Incl Extra Items	813M	679M	2.7B	2.66B	1.08B
Net Income to Common Excl. Extra Items	813M	679M	2.7B	2.66B	1.08B
Per Share Items
Net EPS - Basic	1.18	0.99	3.93	3.87	1.57
Basic EPS - Continuing Operations	1.18	0.99	3.93	3.87	1.57
Basic Weighted Average Shares Outstanding	689M	689M	689M	689M	689M
Net EPS - Diluted	0.89	0.82	2.94	3.16	1.29
Diluted EPS - Continuing Operations	0.89	0.82	2.94	3.16	1.29
Diluted Weighted Average Shares Outstanding	914M	828M	920M	843M	841M
Normalized Basic EPS	1	0.71	3.56	3.4	1.33
Normalized Diluted EPS	0.76	0.59	2.66	2.78	1.09
Dividend Per Share	-	-	-	-	-
Payout Ratio	12.5	10.82	2.79	0	-
Supplemental Items
EBITDA	1.97B	1.61B	4.96B	4.44B	2.42B
EBITA	1.55B	1.18B	4.51B	3.93B	1.76B
EBIT	1.55B	1.18B	4.51B	3.93B	1.76B
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	24.44	24.27	19.4	21.76	26.68
Total Current Taxes	268M	316M	870M	704M	219M
Total Deferred Taxes	14.65M	-71.82M	-146M	103M	213M
Normalized Net Income	690M	489M	2.45B	2.34B	916M
Interest on Long-Term Debt	42.86M	55.8M	32.61M	43.94M	97.51M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.23B	1.22B	1.38B	1.7B	2.22B
General and Administrative Expenses	946M	981M	945M	1.45B	1.85B
Research And Development Expense From Footnotes	-	-	1.32M	1.32M	538K
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	534M	182M	388M	199M	756M
Total Cash And Short Term Investments	534M	182M	388M	199M	756M
Accounts Receivable, Total	1.85B	2.12B	1.5B	1.49B	939M
Other Receivables	149M	253M	181M	280M	322M
Notes Receivable	3.55M	-	1.32B	-	2.48B
Total Receivables	2B	2.37B	3B	1.77B	3.74B
Inventory	2B	2.21B	3.18B	3.39B	3.53B
Prepaid Expenses	107M	176M	1.82M	2.23M	8.24M
Other Current Assets, Total	398M	1.22B	1.31B	822M	974M
Total Current Assets	5.03B	6.15B	7.88B	6.18B	9.01B
Gross Property Plant And Equipment	9.2B	8.76B	9.44B	11.74B	13.98B
Accumulated Depreciation	-3.47B	-3.54B	-4.03B	-4.31B	-4.96B
Net Property Plant And Equipment	5.73B	5.22B	5.41B	7.43B	9.03B
Long-term Investments	-	-	-	-	-
Goodwill	1.84B	1.84B	1.84B	1.84B	1.84B
Other Intangibles, Total	6.76M	6.32M	5.39M	3.78M	457M
Accounts Receivable Long-Term	-	-	-	-	481M
Loans Receivable Long-Term	78M	670M	-	2.13B	-
Deferred Tax Assets Long-Term	-	-	48.61M	-	-
Deferred Charges Long-Term	1.03M	941K	1.64M	1.45M	916K
Other Long-Term Assets, Total	65.19M	128M	165M	320M	391M
Total Assets	12.75B	14.02B	15.35B	17.91B	21.21B
Liabilities
Accounts Payable, Total	1.28B	1.04B	424M	1.04B	817M
Accrued Expenses, Total	695M	521M	1.54B	936M	693M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	3.13B	3.27B	2.23B	1.31B	3.28B
Current Portion of Leases	225M	122M	105M	141M	144M
Current Income Taxes Payable	10.23M	28.46M	63.16M	-	11.78M
Unearned Revenue Current, Total	-	133M	-	-	-
Other Current Liabilities	213M	858M	907M	448M	433M
Total Current Liabilities	5.56B	5.97B	5.26B	3.88B	5.38B
Long-Term Debt	1.8B	2.32B	1.26B	1.41B	1.81B
Long-Term Leases	546M	280M	345M	623M	548M
Unearned Revenue Non Current	-	-	133M	538M	603M
Deferred Tax Liability Non Current	124M	49.84M	-	84.41M	297M
Other Non Current Liabilities	-1K	-2K	27.02M	29.73M	31.19M
Total Liabilities	8.03B	8.62B	7.03B	6.56B	8.67B
Preferred Stock Non Redeemable	230M	230M	230M	230M	230M
Total Preferred Equity	230M	230M	230M	230M	230M
Common Stock, Total	689M	689M	689M	689M	689M
Additional Paid In Capital	1.43M	1.43M	1.43M	1.43M	1.43M
Retained Earnings	3.8B	4.48B	7.4B	10.43B	11.62B
Total Common Equity	4.49B	5.17B	8.09B	11.12B	12.31B
Minority Interest	-	-	-	-	-
Total Equity	4.72B	5.4B	8.32B	11.35B	12.54B
Total Liabilities And Equity	12.75B	14.02B	15.35B	17.91B	21.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	689M	689M	689M	689M	689M
ECS Total Common Shares Outstanding	689M	689M	689M	689M	689M
Book Value / Share	6.52	7.5	11.75	16.14	17.87
Tangible Book Value	2.65B	3.32B	6.25B	9.28B	10.02B
Tangible Book Value Per Share	3.84	4.83	9.07	13.47	14.54
Total Debt	5.71B	5.99B	3.94B	3.49B	5.78B
Net Debt	5.17B	5.81B	3.55B	3.29B	5.03B
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.44B	1.75B	2.38B	2.11B	2.61B
Inventories - Work In Process, Total	229M	272M	330M	448M	434M
Inventories - Finished Goods, Total	332M	185M	475M	837M	510M
Land - (BS)	21.31M	21.28M	49.63M	52.43M	39.15M
Buildings, Total	3.58B	3.57B	3.77B	4.57B	5.47B
Machinery, Total	3.45B	3.64B	3.92B	4.23B	5.08B
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	5.43M	4.55M	13.72M	140M	157M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	897M	762M	3.01B	2.9B	1.19B
Depreciation & Amortization - CF	634M	657M	538M	669M	832M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	518K	1.62M	732K
Depreciation & Amortization, Total	634M	657M	539M	670M	833M
Amortization of Deferred Charges, Total - (CF)	-	-	1.32M	184K	13.4M
(Gain) Loss From Sale Of Asset	-23.11M	-223M	-21.86M	40.44M	72.36M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	210M	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-57.23M	320M	523M	325M	-506M
Change In Accounts Receivable	-281M	-1.05B	753M	558M	-116M
Change In Inventories	29.14M	-214M	-975M	-204M	-156M
Change In Accounts Payable	339M	-309M	-132M	-960M	-
Change in Unearned Revenues	-	133M	-	405M	64.84M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	1.54B	77.55M	3.91B	3.74B	1.39B
Capital Expenditure	-708M	-500M	-869M	-2.35B	-2.98B
Sale of Property, Plant, and Equipment	11.11M	45.45M	204K	14.03M	27.06M
Investment in Marketable and Equity Securities, Total	3.37M	4.08M	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-38M	-562M	-567M	-640M	-
Other Investing Activities, Total	15.89M	10.32M	26.38M	8.64M	38.08M
Cash from Investing	-716M	-1B	-1.41B	-2.97B	-2.92B
Long-Term Debt Issued, Total	5.54B	6.88B	6.43B	4.19B	5.57B
Total Debt Issued	5.54B	6.88B	6.43B	4.19B	5.57B
Long-Term Debt Repaid, Total	-5.73B	-6.22B	-8.64B	-5.14B	-3.49B
Total Debt Repaid	-5.73B	-6.22B	-8.64B	-5.14B	-3.49B
Common & Preferred Stock Dividends Paid	-112M	-82.38M	-83.86M	-41K	-
Common & Preferred Stock Dividends Paid	-112M	-82.38M	-83.86M	-41K	-
Other Financing Activities, Total	-	-	-	-	1K
Cash from Financing	-299M	572M	-2.29B	-954M	2.08B
Miscellaneous Cash Flow Adjustments	-	1K	-	-	-
Net Change in Cash	523M	-353M	206M	-190M	558M
Supplemental Items
Cash Interest Paid	328M	340M	532M	333M	486M
Cash Income Tax Paid (Refund)	343M	264M	772M	796M	179M
Levered Free Cash Flow	855M	-466M	1.08B	1.23B	-4.18B
Unlevered Free Cash Flow	1.1B	-198M	1.46B	1.44B	-3.77B
Change In Net Working Capital	-206M	1.09B	1.04B	-669M	2.74B
Net Debt Issued / Repaid	-187M	655M	-2.21B	-954M	2.08B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	8.06	5.51	19.21	14.78	5.61
Return on Total Capital	9.76	6.76	23.85	18.04	6.62
Return On Equity %	20.71	15.05	43.84	29.31	9.94
Return on Common Equity	19.84	14.06	40.78	27.55	9.26
Margin Analysis
Gross Profit Margin %	30.58	25.3	44.85	41.21	35.69
SG&A Margin	14.98	14.72	14.2	18	25
EBITDA Margin %	13.51	10.78	30.31	25.42	14.84
EBITA Margin %	10.63	7.87	27.57	22.47	10.78
EBIT Margin %	10.63	7.87	27.57	22.46	10.78
Income From Continuing Operations Margin %	6.16	5.08	18.37	16.59	7.29
Net Income Margin %	6.16	5.08	18.37	16.59	7.29
Net Avail. For Common Margin %	5.59	4.53	16.52	15.23	6.66
Normalized Net Income Margin	4.74	3.27	14.97	13.38	5.62
Levered Free Cash Flow Margin	5.88	-3.11	6.6	7.05	-25.65
Unlevered Free Cash Flow Margin	7.54	-1.32	8.89	8.24	-23.17
Asset Turnover
Asset Turnover	1.21	1.12	1.11	1.05	0.83
Fixed Assets Turnover	2.69	2.74	3.08	2.72	1.98
Receivables Turnover (Average Receivables)	8.07	7.56	9.05	13.93	13.4
Inventory Turnover (Average Inventory)	5.03	5.32	3.35	3.13	3.03
Short Term Liquidity
Current Ratio	0.91	1.03	1.5	1.6	1.67
Quick Ratio	0.46	0.43	0.39	0.51	0.37
Operating Cash Flow to Current Liabilities	0.28	0.01	0.74	0.96	0.26
Days Sales Outstanding (Average Receivables)	45.36	48.3	40.33	26.2	27.32
Days Outstanding Inventory (Average Inventory)	72.82	68.57	109.01	116.67	120.93
Average Days Payable Outstanding	35.71	37.13	26.69	25.44	31.97
Cash Conversion Cycle (Average Days)	82.47	79.74	122.64	117.43	116.27
Long Term Solvency
Total Debt/Equity	120.86	111.02	47.32	30.72	46.12
Total Debt / Total Capital	54.72	52.61	32.12	23.5	31.56
LT Debt/Equity	49.71	48.22	19.31	17.91	18.78
Long-Term Debt / Total Capital	22.51	22.85	13.11	13.7	12.85
Total Liabilities / Total Assets	62.97	61.5	45.79	36.63	40.88
EBIT / Interest Expense	3.98	2.75	7.54	11.75	2.73
EBITDA / Interest Expense	5.61	4.28	8.44	13.75	4.02
(EBITDA - Capex) / Interest Expense	3.79	3.11	6.99	6.71	-0.61
Total Debt / EBITDA	2.62	3.26	0.78	0.76	2.23
Net Debt / EBITDA	2.37	3.16	0.7	0.71	1.94
Total Debt / (EBITDA - Capex)	3.88	4.48	0.94	1.55	-14.75
Net Debt / (EBITDA - Capex)	3.51	4.35	0.85	1.46	-12.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-1.98	2.94	9.29	6.81	-6.86
Gross Profit, 1 Yr. Growth %	4.68	-14.83	97.19	-3.85	-19.33
EBITDA, 1 Yr. Growth %	-11.87	-17.9	207.51	-13.11	-44.01
EBITA, 1 Yr. Growth %	-19.69	-23.73	282.24	-15.77	-53.79
EBIT, 1 Yr. Growth %	-19.69	-23.73	282.67	-15.8	-53.79
Earnings From Cont. Operations, 1 Yr. Growth %	-18.17	-15.05	295	-7.3	-59.07
Net Income, 1 Yr. Growth %	-18.17	-15.05	295	-7.3	-59.07
Normalized Net Income, 1 Yr. Growth %	-23.15	-29.11	400.81	-8.05	-59.49
Diluted EPS Before Extra, 1 Yr. Growth %	-16.82	-16.33	258.54	-7.33	-59.18
Accounts Receivable, 1 Yr. Growth %	4.88	14.7	-29.18	46.47	-37.06
Inventory, 1 Yr. Growth %	-1.44	10.71	44.13	6.42	4.29
Net Property, Plant and Equip., 1 Yr. Growth %	12.66	-8.78	3.62	37.3	21.47
Total Assets, 1 Yr. Growth %	13.42	9.96	9.51	16.88	18.42
Tangible Book Value, 1 Yr. Growth %	42.53	25.61	88.01	45.6	7.95
Common Equity, 1 Yr. Growth %	21.15	15.08	56.6	35.35	10.71
Cash From Operations, 1 Yr. Growth %	9.49	-94.96	4.94K	-4.35	-62.72
Capital Expenditures, 1 Yr. Growth %	18.09	-29.42	73.76	170.98	26.66
Levered Free Cash Flow, 1 Yr. Growth %	145.34	-154.5	-280.55	-18.18	-462.66
Unlevered Free Cash Flow, 1 Yr. Growth %	63.99	-118	-540.39	-23.35	-377.37
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.78	0.45	6.07	8.04	-0.26
Gross Profit, 2 Yr. CAGR %	0.18	-5.58	28.46	39.11	-11.93
EBITDA, 2 Yr. CAGR %	-2.43	-14.94	58.88	65.94	-31.26
EBITA, 2 Yr. CAGR %	-7.68	-21.74	70.85	82.41	-38.64
EBIT, 2 Yr. CAGR %	-7.64	-21.74	70.84	82.49	-38.65
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.44	-16.63	83.18	95.17	-38.4
Net Income, 2 Yr. CAGR %	-1.14	-16.63	83.18	95.17	-38.4
Normalized Net Income, 2 Yr. CAGR %	-2.27	-26.19	88.43	118.7	-40.02
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.8	-12.46	73.21	96.31	-38.49
Accounts Receivable, 2 Yr. CAGR %	8.81	9.68	-9.87	-16.07	-3.99
Inventory, 2 Yr. CAGR %	6.06	4.46	26.32	23.85	5.35
Net Property, Plant and Equip., 2 Yr. CAGR %	9.27	1.37	-2.78	19.28	29.14
Total Assets, 2 Yr. CAGR %	9.4	11.68	9.73	13.02	17.65
Tangible Book Value, 2 Yr. CAGR %	77.61	33.81	53.69	67.05	25.37
Common Equity, 2 Yr. CAGR %	29.19	18.08	34.25	46.67	22.41
Cash From Operations, 2 Yr. CAGR %	17.32	-76.5	59.39	594.05	-40.28
Capital Expenditures, 2 Yr. CAGR %	-22.33	-8.7	10.74	116.99	85.26
Levered Free Cash Flow, 2 Yr. CAGR %	84.38	15.64	12.45	43.43	66.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	382.18	-45.66	15.14	108.82	41.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.68	0.44	3.31	6.32	2.83
Gross Profit, 3 Yr. CAGR %	10.46	-5.09	19.99	17.43	16
EBITDA, 3 Yr. CAGR %	10.69	-7.89	30.54	31.24	14.4
EBITA, 3 Yr. CAGR %	9.99	-13.37	32.84	36.46	14.15
EBIT, 3 Yr. CAGR %	10.06	-13.35	32.83	36.44	14.18
Earnings From Cont. Operations, 3 Yr. CAGR %	11.46	-11.35	40.03	47.91	15.96
Net Income, 3 Yr. CAGR %	18.17	-6.02	40.03	47.91	15.96
Normalized Net Income, 3 Yr. CAGR %	21	-12.19	39.74	50.23	23.23
Diluted EPS Before Extra, 3 Yr. CAGR %	12.21	-8.49	40.06	47.74	16.3
Accounts Receivable, 3 Yr. CAGR %	21.01	10.74	-5.2	-6.86	-23.75
Inventory, 3 Yr. CAGR %	8.1	7.59	16.29	19.3	16.95
Net Property, Plant and Equip., 3 Yr. CAGR %	14.02	2.89	2.12	9.08	20.01
Total Assets, 3 Yr. CAGR %	13.12	9.59	10.95	11.99	14.79
Tangible Book Value, 3 Yr. CAGR %	111.77	58.25	49.87	51.91	44.42
Common Equity, 3 Yr. CAGR %	28.17	24.31	29.73	35.28	33.54
Cash From Operations, 3 Yr. CAGR %	30.05	-58.9	40.64	34.44	161.87
Capital Expenditures, 3 Yr. CAGR %	-14.83	-24.77	13.14	49.23	81.34
Levered Free Cash Flow, 3 Yr. CAGR %	24.51	22.82	45.85	12.95	91.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	68.69	61.16	29.55	9.49	125.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.49	10.16	9.4	3.42	1.87
Gross Profit, 5 Yr. CAGR %	11.44	4.03	17.34	10.2	6.46
EBITDA, 5 Yr. CAGR %	10.56	3.1	27.91	16.56	1.61
EBITA, 5 Yr. CAGR %	9.16	-0.4	31.18	16.71	-1.82
EBIT, 5 Yr. CAGR %	9.21	-0.36	31.23	16.73	-1.83
Earnings From Cont. Operations, 5 Yr. CAGR %	28.97	3.21	35.96	21.55	1.62
Net Income, 5 Yr. CAGR %	28.97	3.21	40.82	25.89	1.62
Normalized Net Income, 5 Yr. CAGR %	28.08	-1.98	44.45	26.5	0.39
Diluted EPS Before Extra, 5 Yr. CAGR %	26.61	2.98	36.08	24.18	3.81
Accounts Receivable, 5 Yr. CAGR %	29.78	20.1	7.56	-0.88	-11.81
Inventory, 5 Yr. CAGR %	8.85	10.74	15.05	13.82	11.78
Net Property, Plant and Equip., 5 Yr. CAGR %	18.89	12.89	6.98	9.15	12.17
Total Assets, 5 Yr. CAGR %	14.05	13.42	11.75	10.95	13.54
Tangible Book Value, 5 Yr. CAGR %	76.47	57.21	86.28	61.71	40.08
Common Equity, 5 Yr. CAGR %	16.57	18.36	30.57	32.81	27.13
Cash From Operations, 5 Yr. CAGR %	85.81	-12.99	41.07	27.31	-0.16
Capital Expenditures, 5 Yr. CAGR %	39.41	6.74	-5.4	14.92	37.81
Levered Free Cash Flow, 5 Yr. CAGR %	30.05	77.97	19.54	37.41	64.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	91.55	-3.64	44.79	98.11	41.33